Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics that target the chemokine and chemoattractant systems in order to treat autoimmune diseases, inflammatory disorders and cancer. The chemokine system is a complex network of chemokine molecules, or ligands, and receptors that regulates inflammation. Based on their proprietary drug discovery and drug development platform, ChemoCentryx has generated, internally, several clinical and preclinical stage programs, each targeting distinct chemokine and chemoattractant receptors with different small molecule ( www.chemocentryx.com )
ChemoCentryx , Inc.
1539 Industrial Road
San Carlos, California 94070
USA
Tel: (650) 632-2900
Fax: (650) 632-2910